𝐋𝐢𝐚𝐭 𝐏𝐫𝐢𝐦𝐨𝐫 𝐚𝐧𝐝 𝐡𝐞𝐫 𝐭𝐞𝐚𝐦 𝐚𝐫𝐞 𝐭𝐚𝐜𝐤𝐥𝐢𝐧𝐠 𝐚 𝐦𝐚𝐣𝐨𝐫 𝐩𝐫𝐨𝐛𝐥𝐞𝐦 𝐭𝐡𝐚𝐭'𝐬 𝐜𝐨𝐬𝐭𝐢𝐧𝐠 𝐨𝐯𝐞𝐫 $𝟓𝟎𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐚𝐧𝐧𝐮𝐚𝐥𝐥𝐲 𝐢𝐧 𝐭𝐡𝐞 𝐔.𝐒., 𝐚𝐧𝐝 𝐢𝐭'𝐬 𝐦𝐨𝐬𝐭𝐥𝐲 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐚𝐛𝐥𝐞.
I recently sat down with Liat, Co-founder and CEO of FeelBetter, a Boston startup that’s creating solutions for polypharmacy, a widespread problem impacting millions of Americans.
Polypharmacy is the use of multiple medications by a single individual to manage complicated health conditions.
Simply put, polypharmacy causes:
✅ increased risk of bad drug interactions
✅ side effects
✅ medication errors
✅ lower adherence
Before FeelBetter, Liat worked at Teva Pharmaceuticals, the largest producer of generics, as VP of Global Portfolio for Generic Medicines.
During her time there, Liat saw patients struggling to juggle large bags of medications, a challenge she personally faced when dealing with her own health issues.
She knew there had to be a way to use tech to help healthcare workers reduce the downsides of polypharmacy, and she searched for solutions but found nothing. But her search led to cofounder Yoram Hordan, CTO and COO of FeelBetter, and together they launched the company.
𝐋𝐢𝐚𝐭 𝐚𝐧𝐝 𝐘𝐨𝐫𝐚𝐦 𝐫𝐚𝐢𝐬𝐞𝐝 $𝟏𝟎.𝟓 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐚𝐧𝐝 𝐚𝐬𝐬𝐞𝐦𝐛𝐥𝐞𝐝 𝐚 𝐭𝐞𝐚𝐦 𝐨𝐟 𝟏𝟕 𝐭𝐨 𝐛𝐮𝐢𝐥𝐝 𝐚 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐭𝐨 𝐬𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐳𝐞:
🔍 pharmacology data
🔍 health status
🔍 medical history
🔍 clinical guidelines
🔍 evidence-based medicine.
FeelBetter uses AI to analyze all this data and give clinicians actionable insights to reduce negative effects of polypharmacy.
FeelBetter also identifies at-risk patients and gaps in care in order to enhance well-being and outcomes.
A study conducted with Mass General Brigham showed that FeelBetter could predict which patients would require hospitalization based on medication combinations, highlighting the platform's potential to impact care and outcomes.
The company was started in Israel where there is comprehensive access to patient data, and it's now expanding across the US and collaborating closely with Medicare Advantage programs, Mass General, Atlantic Health, and senior care facilities nationwide.
Connect with Liat Primor to learn more.
And be sure to subscribe to Tribe newsletter for the full story.
#innovation
#management
#technology
Chief Scientific Officer | 2023 PharmaVoice 100 | Engineer + Epidemiologist | Scientific and Strategic Advisor | Advocate for Women in STEM
1moFinding ways to use AI to help patients find and stay on appropriate treatments is one of its most impactful applications. Glad to be a part of this conversation highlighting the strides our industry is making in this space.